Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VistaLink is a Belgium-based industrial automation and machine-vision company that has served pharmaceutical and other regulated manufacturing markets. The company specialized in automated inspection and verification, industrial image processing, serialization, track-and-trace, and related digitalization capabilities used across life sciences operations. VistaLink became part of the CXV Global alliance in 2020 alongside Crest Solutions and Xyntek, and that group later combined with Panacea Technologies in 2022. The combined business was subsequently rebranded as Catalyx, which now provides broader automation, process control, and operational optimization services for pharmaceutical, biotech, and medical technology customers. VistaLink therefore appears best characterized as a healthcare-adjacent life sciences operations technology company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VistaLink.